GR3029590T3 - Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine - Google Patents

Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine

Info

Publication number
GR3029590T3
GR3029590T3 GR990400677T GR990400677T GR3029590T3 GR 3029590 T3 GR3029590 T3 GR 3029590T3 GR 990400677 T GR990400677 T GR 990400677T GR 990400677 T GR990400677 T GR 990400677T GR 3029590 T3 GR3029590 T3 GR 3029590T3
Authority
GR
Greece
Prior art keywords
polymorphic form
crystalline
mesyllysylamino
cyclopentylcarbonyl
tyrosine
Prior art date
Application number
GR990400677T
Other languages
English (en)
Inventor
Peter James Dunn
Michael Leslie Hughes
Original Assignee
Pfizer Ltd
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd, Pfizer Res & Dev filed Critical Pfizer Ltd
Publication of GR3029590T3 publication Critical patent/GR3029590T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
GR990400677T 1993-12-04 1999-03-05 Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine GR3029590T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939324931A GB9324931D0 (en) 1993-12-04 1993-12-04 Glutaramide derivatives
PCT/EP1994/003750 WO1995015308A1 (en) 1993-12-04 1994-11-09 Crystalline, polymorphic form of (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine

Publications (1)

Publication Number Publication Date
GR3029590T3 true GR3029590T3 (en) 1999-06-30

Family

ID=10746163

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990400677T GR3029590T3 (en) 1993-12-04 1999-03-05 Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine

Country Status (26)

Country Link
US (1) US6180665B1 (el)
EP (1) EP0731787B1 (el)
JP (1) JP2701988B2 (el)
KR (1) KR100203314B1 (el)
CN (1) CN1068586C (el)
AT (1) ATE175664T1 (el)
CA (1) CA2178085C (el)
CZ (1) CZ296428B6 (el)
DE (1) DE69416003T2 (el)
DK (1) DK0731787T3 (el)
EG (1) EG20562A (el)
ES (1) ES2128031T3 (el)
FI (1) FI120305B (el)
GB (1) GB9324931D0 (el)
GR (1) GR3029590T3 (el)
HU (1) HU225959B1 (el)
IL (1) IL111791A (el)
MY (1) MY115430A (el)
NO (1) NO306714B1 (el)
NZ (1) NZ276087A (el)
PE (1) PE9296A1 (el)
PL (1) PL178559B1 (el)
RU (1) RU2131869C1 (el)
TW (2) TW534901B (el)
WO (1) WO1995015308A1 (el)
ZA (1) ZA949595B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2420043A1 (en) 2000-08-29 2002-03-07 Riverside Forest Products Limited Collapsible bin
FR2824477B1 (fr) * 2001-05-09 2005-09-09 Ethypharm Lab Prod Ethiques Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes
US6975515B2 (en) 2001-08-15 2005-12-13 Agilent Technologies, Inc. Electrical module
CN102285916B (zh) * 2003-02-12 2015-02-25 日产化学工业株式会社 匹伐他汀钙的晶形
WO2005123702A1 (en) * 2004-06-15 2005-12-29 Pfizer Limited Neutral endopeptidase inhibitor polymorph
CN109350736A (zh) * 2018-09-20 2019-02-19 南通大学 防治运动病、梅尼埃病的药物及心房钠尿肽的医药用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8820844D0 (en) * 1988-09-05 1988-10-05 Pfizer Ltd Therapeutic agents
US5208236A (en) * 1992-09-23 1993-05-04 Schering Corporation N-(acylaminomethyl)glutaryl amino acids and use

Also Published As

Publication number Publication date
CN1068586C (zh) 2001-07-18
NO962294L (no) 1996-06-04
JPH09500654A (ja) 1997-01-21
ES2128031T3 (es) 1999-05-01
CN1142816A (zh) 1997-02-12
EP0731787A1 (en) 1996-09-18
CZ160496A3 (en) 1996-11-13
NO306714B1 (no) 1999-12-13
NO962294D0 (no) 1996-06-04
TW534901B (en) 2003-06-01
CA2178085A1 (en) 1995-06-08
US6180665B1 (en) 2001-01-30
NZ276087A (en) 1997-11-24
EG20562A (en) 1999-08-30
IL111791A (en) 2002-09-12
KR960706470A (ko) 1996-12-09
HU225959B1 (en) 2008-01-28
RU2131869C1 (ru) 1999-06-20
HU9601506D0 (en) 1996-07-29
JP2701988B2 (ja) 1998-01-21
PL178559B1 (pl) 2000-05-31
ZA949595B (en) 1996-06-03
FI962322A0 (fi) 1996-06-03
AU684114B2 (en) 1997-12-04
CA2178085C (en) 2002-09-03
FI962322A (fi) 1996-06-03
HUT74683A (en) 1997-01-28
KR100203314B1 (ko) 1999-06-15
MY115430A (en) 2003-06-30
IL111791A0 (en) 1995-01-24
CZ296428B6 (cs) 2006-03-15
ATE175664T1 (de) 1999-01-15
AU8142494A (en) 1995-06-19
DE69416003T2 (de) 1999-05-27
DK0731787T3 (da) 1999-08-30
DE69416003D1 (en) 1999-02-25
WO1995015308A1 (en) 1995-06-08
TW434210B (en) 2001-05-16
GB9324931D0 (en) 1994-01-26
FI120305B (fi) 2009-09-15
PE9296A1 (es) 1996-04-04
PL314794A1 (en) 1996-09-30
EP0731787B1 (en) 1999-01-13

Similar Documents

Publication Publication Date Title
BG103485A (en) Ketobanzamides as calpain inhibitors
IL135536A0 (en) Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same
NZ279397A (en) Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives and pharmaceutucal compositions
YU41199A (sh) Hinoksalindioni
ES477832A1 (es) Un procedimiento para la preparacion de derivados de diben- zopirano.
IL112622A (en) Iminoalkylamino or aminoalkylideneamino camptothecin derivatives, process for their preparation and pharmaceutical compositions containing them
MY110747A (en) Quinolone-and naphthyridonecarboxylic acid derivatives
CA2080249A1 (en) Preparation of substituted piperidines
HU9401584D0 (en) Preparation of substituted piperidines
NZ331875A (en) Asymmetric synthesis of R-alpha-propyl-piperonyl amine and its analogs
IL111966A0 (en) 4-Benzoylisoxazole derivatives, their preparation and herbicidal compositions containing them
IL107068A0 (en) 5-oxo-dibenzo(a,d)cyclohepta-1,4-dienes,their preparation and pharmaceutical compositions containing them
GR3029590T3 (en) Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
TW252979B (el)
GR3017348T3 (en) Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same.
NZ279396A (en) Octahydro-6-hetring[2,1-a][2]benzazepine disulphide derivatives
IL138638A0 (en) Processes for preparing intermediates
ATE282608T1 (de) Chinoxalindionen
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
HU9600300D0 (en) Thiocarbamoyl derivatives using as antimicrobial agents and process for producing of these
CA2177586A1 (en) 4-benzoylisoxazoles and their use as herbicides